Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research.

作者: Steven K. Takemoto , Wolfgang Arns , Suphamai Bunnapradist , Louis P. Garrison , Lluis Guirado

DOI: 10.1097/TP.0B013E31817D4DF5

关键词:

摘要: Transplantation offers a unique opportunity to demonstrate the complementary roles of randomized controlled trials and outcome research. The surgery collaboration necessary for transplant procedure makes randomization blinding difficult. Because essentially every recipient is included in registry, sampling bias minimized. Regulatory agencies generally do not consider outcomes research when assessing efficacy new drugs or medical interventions. This workgroup summary examines suitability complement results related issues: versus effectiveness, internal external validity, data types, limitations, analysis methodologies. Many advances have been pioneered transplantation. A case made regulatory reimbursement authorities use making efficacy, coverage decisions

参考文章(80)
MacLehose, Reeves, Harvey, Sheldon, Russell, Black, A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. Health Technology Assessment. ,vol. 4, pp. 1- 154 ,(2000) , 10.3310/HTA4340
Y Vanrenterghem, H Ekberg, J Grinyo, G Tufveson, C Groth, D Cantarovich, L Mjornstedt, S Sadek, R Pichlmayr, F Moreso, G Gannedahl, P Lang, Adam Tegzess, J Rodicio, van Willem Son, A Morgan, A Tarantino, J Peeters, M Campise, J Lodge, K Hutchinson, J Erhard, K Wagner, L Hooftman, S Carl, G Ligtenberg, G Thiel, R Luck, M Wiesel, M Zeiler, Hh Neumayer, Sa Sadek, Jp Soulillou, K Rigg, B Bourgeon, P Fauchald, Hauser, C Brattstrom, R Hene, M Behrend, D Albrechtsen, N Persson, J Morales, PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION The Lancet. ,vol. 345, pp. 1321- 1325 ,(1995)
Thomas E. Burroughs, Jason Swindle, Steven Takemoto, Krista L. Lentine, Gerardo Machnicki, William D. Irish, Daniel C. Brennan, Mark A. Schnitzler, Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation. ,vol. 83, pp. 1027- 1034 ,(2007) , 10.1097/01.TP.0000259617.21741.95
Gordon H. Guyatt, R. Brian Haynes, Roman Z. Jaeschke, Deborah J. Cook, Lee Green, C. David Naylor, Mark C. Wilson, W. Scott Richardson, for the Evidence-Based Medicine Working Group, Users' Guides to the Medical Literature JAMA. ,vol. 284, pp. 1290- 1296 ,(2000) , 10.1001/JAMA.284.10.1290
Martin T.R. Grapow, Robert von Wattenwyl, Ulrich Guller, Friedhelm Beyersdorf, Hans-Reinhard Zerkowski, Randomized controlled trials do not reflect reality: Real-world analyses are critical for treatment guidelines! The Journal of Thoracic and Cardiovascular Surgery. ,vol. 132, pp. 5- 7 ,(2006) , 10.1016/J.JTCVS.2006.03.035
David C. Cone, Roger J. Lewis, Should this study change my practice Academic Emergency Medicine. ,vol. 10, pp. 417- 422 ,(2003) , 10.1111/J.1553-2712.2003.TB00621.X
Bertram L. Kasiske, Jon J. Snyder, David Gilbertson, Ajthur J. Matas, Diabetes Mellitus after Kidney Transplantation in the United States American Journal of Transplantation. ,vol. 3, pp. 178- 185 ,(2003) , 10.1034/J.1600-6143.2003.00010.X
Suphamai Bunnapradist, Krista L. Lentine, Thomas E. Burroughs, Brett W. Pinsky, Karen L. Hardinger, Daniel C. Brennan, Mark A. Schnitzler, Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure Transplantation. ,vol. 82, pp. 102- 107 ,(2006) , 10.1097/01.TP.0000225760.09969.1F
Gerardo Machnicki, Louiza Seriai, Mark A. Schnitzler, Economics of transplantation: a review of the literature Transplantation Reviews. ,vol. 20, pp. 61- 75 ,(2006) , 10.1016/J.TRRE.2006.05.001